NOX1 and cancer: Although the pathway is typically up-regulated in cancer cells in order to support sustained energy production and biosynthesis, our results suggest that NOX1 acts to inhibit anaplerosis and redirect glutamate from the TCA cycle towards conversion to aspartate (Fig. 6).